Terms: = Prostate cancer AND HMGA1, MGC4242, 3159, ENSG00000137309, MGC12816, HMGIY, P17096, MGC4854, HMG-R
20 results:
1. PTML Combinatorial Model of ChEMBL Compounds Assays for Multiple Types of cancer.
Bediaga H; Arrasate S; González-Díaz H
ACS Comb Sci; 2018 Nov; 20(11):621-632. PubMed ID: 30240186
[TBL] [Abstract] [Full Text] [Related]
2. Association Between Neighborhood Cohesion and cancer Screening Utilization in Chinese American Older Adults.
Hei A; Simon MA; Dong X
J Immigr Minor Health; 2019 Aug; 21(4):830-836. PubMed ID: 29980880
[TBL] [Abstract] [Full Text] [Related]
3. Heme oxygenase-1 in the forefront of a multi-molecular network that governs cell-cell contacts and filopodia-induced zippering in prostate cancer.
Paez AV; Pallavicini C; Schuster F; Valacco MP; Giudice J; Ortiz EG; Anselmino N; Labanca E; Binaghi M; Salierno M; Martí MA; Cotignola JH; Woloszynska-Read A; Bruno L; Levi V; Navone N; Vazquez ES; Gueron G
Cell Death Dis; 2016 Dec; 7(12):e2570. PubMed ID: 28032857
[TBL] [Abstract] [Full Text] [Related]
4. Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis.
Qi C; Bin Li ; Yang Y; Yang Y; Li J; Zhou Q; Wen Y; Zeng C; Zheng L; Zhang Q; Li J; He X; Zhou J; Shao C; Wang L
Sci Rep; 2016 Jun; 6():27819. PubMed ID: 27292155
[TBL] [Abstract] [Full Text] [Related]
5. Downregulation of miR-195 promotes prostate cancer progression by targeting hmga1.
Zhang X; Tao T; Liu C; Guan H; Huang Y; Xu B; Chen M
Oncol Rep; 2016 Jul; 36(1):376-82. PubMed ID: 27175617
[TBL] [Abstract] [Full Text] [Related]
6. Molecular aspects on adriamycin interaction with hmga1 regulatory region and its inhibitory effect on hmga1 expression in human cervical cancer.
Akhter MZ; Luthra K; Rajeswari MR
J Biomol Struct Dyn; 2016; 34(4):877-91. PubMed ID: 26084422
[TBL] [Abstract] [Full Text] [Related]
7. Hsa-miRNA-765 as a key mediator for inhibiting growth, migration and invasion in fulvestrant-treated prostate cancer.
Leung YK; Chan QK; Ng CF; Ma FM; Tse HM; To KF; Maranchie J; Ho SM; Lau KM
PLoS One; 2014; 9(5):e98037. PubMed ID: 24837491
[TBL] [Abstract] [Full Text] [Related]
8. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
Schubert M; Spahn M; Kneitz S; Scholz CJ; Joniau S; Stroebel P; Riedmiller H; Kneitz B
PLoS One; 2013; 8(6):e65064. PubMed ID: 23798998
[TBL] [Abstract] [Full Text] [Related]
9. High mobility group protein AT-hook 1 (hmga1) is associated with the development of androgen independence in prostate cancer cells.
Takeuchi I; Takaha N; Nakamura T; Hongo F; Mikami K; Kamoi K; Okihara K; Kawauchi A; Miki T
Prostate; 2012 Jul; 72(10):1124-32. PubMed ID: 22213442
[TBL] [Abstract] [Full Text] [Related]
10. Regulation of hmga1 expression by microRNA-296 affects prostate cancer growth and invasion.
Wei JJ; Wu X; Peng Y; Shi G; Basturk O; Yang X; Daniels G; Osman I; Ouyang J; Hernando E; Pellicer A; Rhim JS; Melamed J; Lee P
Clin Cancer Res; 2011 Mar; 17(6):1297-305. PubMed ID: 21138859
[TBL] [Abstract] [Full Text] [Related]
11. A quantitative study on the in vitro and in vivo acetylation of high mobility group A1 proteins.
Zhang Q; Zhang K; Zou Y; Perna A; Wang Y
J Am Soc Mass Spectrom; 2007 Sep; 18(9):1569-78. PubMed ID: 17627840
[TBL] [Abstract] [Full Text] [Related]
12. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy).
Tewari A; Raman JD; Chang P; Rao S; Divine G; Menon M
Urology; 2006 Dec; 68(6):1268-74. PubMed ID: 17169648
[TBL] [Abstract] [Full Text] [Related]
13. Acetylation and phosphorylation of high-mobility group A1 proteins in PC-3 human tumor cells.
Jiang X; Wang Y
Biochemistry; 2006 Jun; 45(23):7194-201. PubMed ID: 16752910
[TBL] [Abstract] [Full Text] [Related]
14. Tandem mass spectrometry for the examination of the posttranslational modifications of high-mobility group A1 proteins: symmetric and asymmetric dimethylation of Arg25 in hmga1a protein.
Zou Y; Wang Y
Biochemistry; 2005 Apr; 44(16):6293-301. PubMed ID: 15835918
[TBL] [Abstract] [Full Text] [Related]
15. High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cells.
Takaha N; Resar LM; Vindivich D; Coffey DS
Prostate; 2004 Jul; 60(2):160-7. PubMed ID: 15162382
[TBL] [Abstract] [Full Text] [Related]
16. High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells.
Takaha N; Hawkins AL; Griffin CA; Isaacs WB; Coffey DS
Cancer Res; 2002 Feb; 62(3):647-51. PubMed ID: 11830513
[TBL] [Abstract] [Full Text] [Related]
17. High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases.
Chiappetta G; Manfioletti G; Pentimalli F; Abe N; Di Bonito M; Vento MT; Giuliano A; Fedele M; Viglietto G; Santoro M; Watanabe T; Giancotti V; Fusco A
Int J Cancer; 2001 Jan; 91(2):147-51. PubMed ID: 11146437
[TBL] [Abstract] [Full Text] [Related]
18. A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization.
Tamimi Y; van der Poel HG; Karthaus HF; Debruyne FM; Schalken JA
Br J Cancer; 1996 Aug; 74(4):573-8. PubMed ID: 8761372
[TBL] [Abstract] [Full Text] [Related]
19. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins.
Fedele M; Bandiera A; Chiappetta G; Battista S; Viglietto G; Manfioletti G; Casamassimi A; Santoro M; Giancotti V; Fusco A
Cancer Res; 1996 Apr; 56(8):1896-901. PubMed ID: 8620511
[TBL] [Abstract] [Full Text] [Related]
20. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization.
Tamimi Y; van der Poel HG; Denyn MM; Umbas R; Karthaus HF; Debruyne FM; Schalken JA
Cancer Res; 1993 Nov; 53(22):5512-6. PubMed ID: 8221692
[TBL] [Abstract] [Full Text] [Related]
